Artisan Aphakia Lens for the Correction of Aphakia in Children
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01547442 |
Recruitment Status :
Recruiting
First Posted : March 7, 2012
Last Update Posted : June 27, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Aphakia | Device: Artisan Aphakia Intraocular Lens | Phase 3 |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 300 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Artisan Aphakia Lens for the Correction of Aphakia in Children |
Study Start Date : | January 2012 |
Estimated Primary Completion Date : | December 2025 |
Estimated Study Completion Date : | December 2025 |

Arm | Intervention/treatment |
---|---|
Experimental: Artisan Aphakia Intraocular Lens
Implantation of an Artisan intraocular lens to correct aphakia in children
|
Device: Artisan Aphakia Intraocular Lens
Implantation of an intraocular lens |
- Best corrected distance visual acuity at 12 months postoperative [ Time Frame: 5 years follow up ]Determination of the ability of the lens to correct refractive error caused by aphakia

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 2 Years to 21 Years (Child, Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- 2 to 21 years of age
- Have a visually significant cataract or need IOL replacement surgery
- Compromised capsular bag prohibiting implantation of standard posterior IOL
- Subject or parent/guardian must be able to comply with visit schedule and study requirements
- Subject's legal representative must be able to sign the Informed Consent
Exclusion Criteria:
- Under 2 years of age
- Unable to meet Postoperative evaluation requirements
- No useful vision or vision potential in fellow eye
- Mentally retarded patients
- History of corneal disease
- Abnormality of the iris or ocular structure
- ACD less than 3.2 mm
- Uncontrolled glaucoma
- IOP > 25 mmHg
- Chronic or recurrent uveitis
- Preexisting macular pathology that may complicate the ability to assess the benefit of this lens
- Retinal detachment or family history
- Retinal disease that may limit visual potential
- Optic nerve disease that may limit visual potential
- Diabetes mellitus
- Pregnant, lactating or plan to become pregnant

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01547442
Contact: Abraham Farhan | 561-989-8767 | abraham.farhan@usa.ophtec.com |

Study Director: | Abraham Farhan | Sponsor GmbH |
Responsible Party: | Ophtec USA |
ClinicalTrials.gov Identifier: | NCT01547442 |
Other Study ID Numbers: |
Artisan Pediatric Aphakia |
First Posted: | March 7, 2012 Key Record Dates |
Last Update Posted: | June 27, 2022 |
Last Verified: | June 2022 |
aphakia secondary intraocular lens congenital cataract marfan syndrome |
pediatric cataract ectopia lentis subluxated lens |
Aphakia Lens Diseases Eye Diseases |